NCT07037888View on ClinicalTrials.gov

Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions
Femoracetabular ImpingementHip Arthroscopy
Interventions
DRUG

Ketorolac

IV ketorolac intraoperative loading dose Ketorolac 10mg 1 tablet q6hrs to start on POD0

DRUG

Control (Standard treatment)

hydrocodone-acetaminophen 5mg/325mg 1 tablet q6hrs PRN to start on POD0 30 tablets

DRUG

Control (Standard treatment)

indomethacin 75mg 1 tablet QD to start on POD0 10 tablets

DRUG

Control (Standard treatment)

diazepam 5mg 1-2 tablets q8hrs PRN to start on POD0 15 tablets

DRUG

Omeprazole

20 mg qd

Trial Locations (1)

48202

RECRUITING

Henry Ford Health, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER